Şemsi N. Babacan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Şemsi N. Babacan has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ilhami Gulcin
Department of Chemistry, Faculty of Science, Atatürk University, 25240 Erzurum, Türkiye
1 shared publication - İrFan Koca
Department of Chemistry, Faculty of Art & Sciences Yozgat Bozok University Yozgat Türkiye
1 shared publication - Mehmet Gümüş
Akdağmadeni Health College, Yozgat Bozok University, Yozgat, Turkey
1 shared publication - Yeliz Demir
Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School Ardahan University Ardahan Türkiye
1 shared publication - Yusuf Sert
Bozok Üniversitesi
1 shared publication
Latest Publications
- Top Cited Papers
- 5 October 2021
- Published by Wiley in Archiv der Pharmazie
- Vol. 355 (1) , e2100242
Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors
Human carbonic anhydrase (hCA) isoenzymes are zinc ion‐containing, widespread metalloenzymes and they classically play a role in pH homeostasis maintenance. CA inhibitors suppress the CA activity and their usage has been clinically established as antiglaucoma agents, antiepileptics, diuretics, and in some other disorders. Alzheimer's disease (AD) is a slowly progressive neurodegenerative disorder and a fatal disease of the brain. An advanced method to cure AD includes the strategy to design acetylcholinesterase (AChE) inhibitors. A novel series of pyrrole‐3‐one derivatives containing sulfa drugs (5a–i) were determined to be highly potent inhibitors for AChE and hCA I and hCA II (inhibitory constant [Ki] values are in the range of 6.50 ± 1.02–37.46 ± 4.12 nM, 1.20 ± 0.19–44.21 ± 1.09 nM, and 8.93 ± 1.58–46.86 ± 8.41 nM for AChE, hCA I, and hCA II, respectively). The designed compounds often show a more effective inhibition than the chemicals used as the standard. Among these compounds, 5f was the most effective compound against hCA I, and compound 5e was the most effective compound against hCA II. It was determined that compound 5c was the most effective inhibitor for AChE.
- 5 October 2021
- Published by Wiley in Archiv der Pharmazie
- Vol. 355 (1) , e2100242
Top Cited PapersDiscovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors
Human carbonic anhydrase (hCA) isoenzymes are zinc ion‐containing, widespread metalloenzymes and they classically play a role in pH homeostasis maintenance. CA inhibitors suppress the CA activity and their usage has been clinically established as antiglaucoma agents, antiepileptics, diuretics, and in some other disorders. Alzheimer's disease (AD) is a slowly progressive neurodegenerative disorder and a fatal disease of the brain. An advanced method to cure AD includes the strategy to design acetylcholinesterase (AChE) inhibitors. A novel series of pyrrole‐3‐one derivatives containing sulfa drugs (5a–i) were determined to be highly potent inhibitors for AChE and hCA I and hCA II (inhibitory constant [Ki] values are in the range of 6.50 ± 1.02–37.46 ± 4.12 nM, 1.20 ± 0.19–44.21 ± 1.09 nM, and 8.93 ± 1.58–46.86 ± 8.41 nM for AChE, hCA I, and hCA II, respectively). The designed compounds often show a more effective inhibition than the chemicals used as the standard. Among these compounds, 5f was the most effective compound against hCA I, and compound 5e was the most effective compound against hCA II. It was determined that compound 5c was the most effective inhibitor for AChE.